Susceptibility to diet-induced hepatic steatosis and glucocorticoid resistance in FK506-binding protein 52-deficient mice

Endocrinology

Volumn 151, Issue 7, 2010, Pages 3225-3236

  Warrier, Manya ^a   Hinds Jr , Terry D ^a   Ledford, Kelly J ^a   Cash, Harrison A ^a   Patel, Payal R ^a   Bowman, Thomas A ^a   Stechschulte, Lance A ^a   Yong, Weidong ^b   Shou, Weinian ^b   Najjar, Sonia M ^a   Sanchez, Edwin R ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CORTICOSTERONE; FATTY ACID SYNTHASE; FK 506 BINDING PROTEIN; GLUCOCORTICOID; GLUCOSE 6 PHOSPHATASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PYRUVATE DEHYDROGENASE KINASE 4; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TUMOR NECROSIS FACTOR ALPHA; CD66 ANTIGENS; CELL ADHESION MOLECULE; GLUCOCORTICOID RECEPTOR; LEUKOCYTE ANTIGEN; TACROLIMUS BINDING PROTEIN 4;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOSTERONE BLOOD LEVEL; DIETARY INTAKE; DISEASE PREDISPOSITION; FATTY LIVER; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLUCONEOGENESIS; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN CLEARANCE; INSULIN RESISTANCE; LIPID DIET; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; WILD TYPE; ANIMAL; BLOOD; CELL CULTURE; CHEMICALLY INDUCED DISORDER; FAT INTAKE; GENETICS; HYPERINSULINISM; MALE; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD; BLOTTING, WESTERN; CELL ADHESION MOLECULES; CELLS, CULTURED; CORTICOSTERONE; DIETARY FATS; DISEASE SUSCEPTIBILITY; FATTY LIVER; HYPERGLYCEMIA; HYPERINSULINISM; MALE; MICE; MICE, KNOCKOUT; POLYMERASE CHAIN REACTION; RECEPTORS, GLUCOCORTICOID; TACROLIMUS BINDING PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954580926     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-1158     Document Type: Article

References (69)

1. Vegiopoulos A, Herzig S 2007 Glucocorticoids, metabolism and metabolic diseases. Mol Cell Endocrinol 275:43-61
2. Peeke PM, Chrousos GP 1995 Hypercortisolism and obesity. Ann NY Acad Sci 771:665-676
3. Beato M, Klug J 2000 Steroid hormone receptors: an update. Hum Reprod Update 6:225-236
4. Tata JR 2002 Signalling through nuclear receptors. Nat Rev Mol Cell Biol 3:702-710
5. Pratt WB, Toft DO 1997 Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 18: 306-360
6. Ratajczak T, Ward BK, Minchin RF 2003 Immunophilin chaperones in steroid receptor signalling. Curr Top Med Chem 3:1348-1357
7. Davies TH, Sánchez ER 2005 Fkbp52. Int J Biochem Cell Biol 37: 42-47.
8. Smith DF, Toft DO 2008 Minireview: the intersection of steroid receptors with molecular chaperones: observations and questions. Mol Endocrinol 22:2229-2240
9. Tranguch S, Cheung-Flynn J, Daikoku T, Prapapanich V, Cox MB, Xie H, Wang H, Das SK, Smith DF, Dey SK 2005 Cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation. Proc Natl Acad Sci USA 102:14326-14331
10. Yang Z, Wolf IM, Chen H, Periyasamy S, Chen Z, Yong W, Shi S, Zhao W, Xu J, Srivastava A, Sánchez ER, Shou W 2006 FK506-binding protein 52 is essential to uterine reproductive physiology controlled by the progesterone receptor a isoform. Mol Endocrinol 20:2682-2694
11. Cheung-Flynn J, Prapapanich V, Cox MB, Riggs DL, Suarez-Quian C, Smith DF 2005 Physiological role for the cochaperone FKBP52 in androgen receptor signaling. Mol Endocrinol 19:1654-1666
12. Yong W, Yang Z, Periyasamy S, Chen H, Yucel S, Li W, Lin LY, Wolf IM, Cohn MJ, Baskin LS, Sánchez ER, Shou W 2007 Essential role for co-chaperone Fkbp52 but not Fkbp51 in androgen receptor-mediated signaling and physiology. J Biol Chem 282:5026-5036
13. Sapolsky RM, Romero LM, Munck AU 2000 How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21:55-89
14. Pilkis SJ, Granner DK 1992 Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Physiol 54: 885-909
15. Hanson RW, Reshef L 1997 Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu Rev Biochem 66: 581-611
16. Hanson RW, Reshef L 2003 Glyceroneogenesis revisited. Biochimie (Paris) 85:1199-1205
17. Huang B, Wu P, Bowker-Kinley MM, Harris RA 2002 Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-α ligands, glucocorticoids, and insulin. Diabetes 51:276-283
18. Andrews RC, Walker BR 1999 Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci (Lond) 96:513-523
19. Walker BR 2006 Cortisol: cause and cure for metabolic syndrome? Diabet Med 23:1281-1288
20. Saad MJ, Folli F, Kahn JA, Kahn CR 1993 Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats. J Clin Invest 92:2065-2072
21. Long W, Barrett EJ, Wei L, Liu Z 2003 Adrenalectomy enhances the insulin sensitivity of muscle protein synthesis. Am J Physiol Endocrinol Metab 284:E102-E109
22. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL 2004 Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117:399-412
23. Cole TG, Wilcox HG, Heimberg M 1982 Effects of adrenalectomy and dexamethasone on hepatic lipid metabolism. J Lipid Res 23: 81-91
24. Mangiapane EH, Brindley DN 1986 Effects of dexamethasone and insulin on the synthesis of triacylglycerols and phosphatidylcholine and the secretion of very-low-density lipoproteins and lysophosphatidylcholine by monolayer cultures of rat hepatocytes. Biochem J 233:151-160
25. Caro JF, Amatruda JM 1982 Glucocorticoid-induced insulin resistance: the importance of postbinding events in the regulation of insulin binding, action, and degradation in freshly isolated and primary cultures of rat hepatocytes. J Clin Invest 69:866-875
26. Amatruda JM, Danahy SA, Chang CL 1983 The effects of glucocorticoids on insulin-stimulated lipogenesis in primary cultures of rat hepatocytes. Biochem J 212:135-141
27. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Shulman GI 1999 Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103:253-259
28. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF, Shulman GI 1999 Free fatty acid-induced insulin resistance is associated with activation of protein kinase Cθ and alterations in the insulin signaling cascade. Diabetes 48:1270-1274
29. Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, Romanelli AJ, Shulman GI 2004 Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 279:32345-32353
30. Formisano P, Najjar SM, Gross CN, Philippe N, Oriente F, Kern-Buell CL, Accili D, Gorden P 1995 Receptor-mediated internalization of insulin. Potential role of pp120/HA4, a substrate of the insulin receptor kinase. J Biol Chem 270:24073-24077
31. Choice CV, Howard MJ, Poy MN, Hankin MH, Najjar SM 1998 Insulin stimulates pp120 endocytosis in cells co-expressing insulin receptors. J Biol Chem 273:22194-22200
32. Najjar SM, Choice CV, Soni P, Whitman CM, Poy MN 1998 Effect of pp120 on receptor-mediated insulin endocytosis is regulated by the juxtamembrane domain of the insulin receptor. J Biol Chem 273:12923-12928
33. Poy MN, Yang Y, Rezaei K, Fernström MA, Lee AD, Kido Y, Erickson SK, Najjar SM 2002 CEACAM1 regulates insulin clearance in liver. Nat Genet 30:270-276
34. DeAngelis AM, Heinrich G, Dai T, Bowman TA, Patel PR, Jun Lee SJ, Hong EG, Jung DY, Assmann A, Kulkarni RN, Kim JK, Najjar SM 2008 Carcinoembryonic antigen-related cell adhesion molecule 1: a link between insulin and lipid metabolism. Diabetes 57:2296-2303
35. Lee SJ, Heinrich G, Fedorova L, Al-Share QY, Ledford KJ, Fernstrom MA, McInerney MF, Erickson SK, Gatto-Weis C, Najjar SM 2008 Development of nonalcoholic steatohepatitis in insulin-resistant liver-specific S503A carcinoembryonic antigen-related cell adhesion molecule 1 mutant mice. Gastroenterology 135:2084-2095
36. Najjar SM, Yang Y, Fernström MA, Lee SJ, Deangelis AM, Rjaily GA, Al-Share QY, Dai T, Miller TA, Ratnam S, Ruch RJ, Smith S, Lin SH, Beauchemin N, Oyarce AM 2005 Insulin acutely decreases hepatic fatty acid synthase activity. Cell Metab 2:43-53
37. Najjar SM, Boisclair YR, Nabih ZT, Philippe N, Imai Y, Suzuki Y, Suh DS, Ooi GT 1996 Cloning and characterization of a functional promoter of the rat pp120 gene, encoding a substrate of the insulin receptor tyrosine kinase. J Biol Chem 271:8809-8817
38. Laemmli UK 1970 Cleavage of structural proteins during the assembly of bacteriophage T4. Nature 227:680-685
39. Beneke S, Rooney SA 2001 Glucocorticoids regulate expression of the fatty acid synthase gene in fetal rat type II cells. Biochim Biophys Acta 1534:56-63
40. Lin HY, Yu IC, Wang RS, Chen YT, Liu NC, Altuwaijri S, Hsu CL, Ma WL, Jokinen J, Sparks JD, Yeh S, Chang C 2008 Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor. Hepatology 47:1924-1935
41. Phan D, Sui X, Chen DT, Najjar SM, Jenster G, Lin SH 2001 Androgen regulation of the cell-cell adhesion molecule-1 (Ceacam1) gene. Mol Cell Endocrinol 184:115-123
42. Lu NZ, Cidlowski JA 2005 Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol Cell 18:331-342
43. Chew GT, Gan SK, Watts GF 2006 Revisiting the metabolic syndrome. Med J Aust 185:445-449
44. Opherk C, Tronche F, Kellendonk C, Kohlmüller D, Schulze A, Schmid W, Schütz G 2004 Inactivation of the glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus. Mol Endocrinol 18:1346-1353
45. Shimomura I, Bashmakov Y, Ikemoto S, Horton JD, Brown MS, Goldstein JL 1999 Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc Natl Acad Sci USA 96:13656-13661
46. Sugden MC, Holness MJ 2003 Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs. Am J Physiol Endocrinol Metab 284:E855-E862
47. Asselin-Labat ML, David M, Biola-Vidamment A, Lecoeuche D, Zennaro MC, Bertoglio J, Pallardy M 2004 GILZ, a new target for the transcription factor FoxO3, protects T lymphocytes from interleukin-2 withdrawal-induced apoptosis. Blood 104:215-223
48. Coletta DK, Balas B, Chavez AO, Baig M, Abdul-Ghani M, Kashyap SR, Folli F, Tripathy D, Mandarino LJ, Cornell JE, Defronzo RA, Jenkinson CP 2008 Effect of acute physiological hyperinsulinemia on gene expression in human skeletal muscle in vivo. Am J Physiol Endocrinol Metab 294:E910-E917
49. Hunt CR, Ro JH, Dobson DE, Min HY, Spiegelman BM 1986 Adipocyte P2 gene: developmental expression and homology of 5′-flanking sequences among fat cell-specific genes. Proc Natl Acad Sci USA 83:3786-3790
50. Sugden MC, Holness MJ 2006 Mechanisms underlying regulation of the expression and activities of the mammalian pyruvate dehydrogenase kinases. Arch Physiol Biochem 112:139-149
51. Patsouris D, Mandard S, Voshol PJ, Escher P, Tan NS, Havekes LM, Koenig W, März W, Tafuri S, Wahli W, Müller M, Kersten S 2004 PPARα governs glycerol metabolism. J Clin Invest 114:94-103
52. Lindén D, William-Olsson L, Ahnmark A, Ekroos K, Hallberg C, Sjögren HP, Becker B, Svensson L, Clapham JC, Oscarsson J, Schreyer S 2006 Liver-directed overexpression of mitochondrial glycerol-3-phosphate acyltransferase results in hepatic steatosis, increased triacylglycerol secretion and reduced fatty acid oxidation. FASEB J 20:434-443
53. Park SY, Cho YR, Kim HJ, Hong EG, Higashimori T, Lee SJ, Goldberg IJ, Shulman GI, Najjar SM, Kim JK 2006 Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. Am J Physiol Endocrinol Metab 291:E517-E524
54. Giudetti AM, Gnoni GV 1998 Short-term effect of dexamethasone on fatty acid and cholesterol synthesis in isolated rat hepatocytes. Biochem Mol Biol Int 44:515-521
55. Lemke U, Krones-Herzig A, Berriel Diaz M, Narvekar P, Ziegler A, Vegiopoulos A, Cato AC, Bohl S, Klingmüller U, Screaton RA, Müller-Decker K, Kersten S, Herzig S 2008 The glucocorticoid receptor controls hepatic dyslipidemia through Hes1. Cell Metab 8:212-223
56. Shteyer E, Liao Y, Muglia LJ, Hruz PW, Rudnick DA 2004 Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice. Hepatology 40:1322-1332
57. Kim JB, Sarraf P, Wright M, Yao KM, Mueller E, Solanes G, Lowell BB, Spiegelman BM 1998 Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. J Clin Invest 101:1-9
58. Foretz M, Pacot C, Dugail I, Lemarchand P, Guichard C, Le Lièpvre X, Berthelier-Lubrano C, Spiegelman B, Kim JB, Ferré P, Foufelle F 1999 ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol Cell Biol 19:3760-3768
59. Dalman FC, Koenig RJ, Perdew GH, Massa E, Pratt WB 1990 In contrast to the glucocorticoid receptor, the thyroid hormone receptor is translated in the DNA binding state and is not associated with hsp90. J Biol Chem 265:3615-3618
60. Chen MS, Silverstein AM, Pratt WB, Chinkers M 1996 The tetratricopeptide repeat domain of protein phosphatase 5 mediates binding to glucocorticoid receptor heterocomplexes and acts as a dominant negative mutant. J Biol Chem 271:32315-32320
61. Silverstein AM, Galigniana MD, Kanelakis KC, Radanyi C, Renoir JM, Pratt WB 1999 Different regions of the immunophilin FKBP52 determine its association with the glucocorticoid receptor, hsp90, and cytoplasmic dynein. J Biol Chem 274:36980-36986
62. Dalman FC, Sturzenbecker LJ, Levin AA, Lucas DA, Perdew GH, Petkovitch M, Chambon P, Grippo JF, Pratt WB 1991 Retinoic acid receptor belongs to a subclass of nuclear receptors that do not form "docking" complexes with hsp90. Biochemistry 30:5605-5608
63. Fukui M, Kitagawa Y, Ose H, Hasegawa G, Yoshikawa T, Nakamura N 2007 Role of endogenous androgen against insulin resistance and athero- sclerosis in men with type 2 diabetes. Curr Diabetes Rev 3:25-31
64. Riggs DL, Roberts PJ, Chirillo SC, Cheung-Flynn J, Prapapanich V, Ratajczak T, Gaber R, Picard D, Smith DF 2003 The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo. EMBO J 22:1158-1167
65. Bryzgalova G, Gao H, Ahren B, Zierath JR, Galuska D, Steiler TL, Dahlman-Wright K, Nilsson S, Gustafsson JA, Efendic S, Khan A 2006 Evidence that oestrogen receptor-α plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia 49:588-597
66. Leung DY, Hamid Q, Vottero A, Szefler SJ, Surs W, Minshall E, Chrousos GP, Klemm DJ 1997 Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor β. J Exp Med 186:1567-1574
67. Kino T, Chrousos GP 2001 Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes. J Endocrinol 169:437-445
68. de Lange P, Koper JW, Huizenga NA, Brinkmann AO, de Jong FH, Karl M, Chrousos GP, Lamberts SW 1997 Differential hormone-dependent transcriptional activation and repression by naturally occurring human glucocorticoid receptor variants. Mol Endocrinol 11:1156-1164
69. Cole TJ, Blendy JA, Monaghan AP, Krieglstein K, Schmid W, Aguzzi A, Fantuzzi G, Hummler E, Unsicker K, Schütz G 1995 Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 9:1608-1621